Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-15 Sale | 2023-02-16 08:48 am | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 3,762 | $8.34 | $31,375 | 173,061 (Direct) | View |
| 2023-01-30 Sale | 2023-01-31 08:28 am | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 10,106 | $8.35 | $84,385 | 176,823 (Direct) | View |
| 2023-01-06 Sale | 2023-01-09 4:13 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 2,893 | $7.25 | $20,974 | 186,929 (Direct) | View |
| 2022-02-14 Sale | 2022-02-16 08:01 am | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 3,762 | $3.09 | $11,625 | 189,822 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 4:17 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 2,894 | $3.19 | $9,232 | 83,084 (Direct) | View |
| 2021-08-16 Sale | 2021-08-17 4:02 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 8,086 | $3.28 | $26,522 | 85,978 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 9:27 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 3,763 | $7.32 | $27,545 | 94,064 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 5:44 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 4,354 | $10.37 | $45,151 | 76,127 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Option Award | 2024-10-01 5:04 pm | N/A 2034-09-29 | Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-03-06 Equity Swap | 2023-03-06 11:36 am | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 80,595 | $0 | 0 (Direct) | View |
| 2023-03-06 Disposition | 2023-03-06 11:36 am | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 579,796 | $0 | 0 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:52 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 4:38 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 4:03 pm | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 110,500 | $0 | 193,584 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:01 pm | N/A 2031-06-15 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-05 Option Award | 2021-01-07 4:35 pm | N/A 2031-01-04 | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 82,100 | $0 | 158,227 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:04 pm | N/A 2030-02-13 | CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer | 70,646 | $0 | 122,911 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:24 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 23,684 | $0 | 23,684 (Direct) | View |